Continuing scientific progress in Parkinson's disease (PD) and other parkinsonian syndromes relies upon accurate diagnosis of these disorders and the availability of patients and controls for study. The Ascertainment and Clinical Core of the Duke Udall Parkinson's Disease Research Center of Excellence (""""""""Duke Udall PDRCE"""""""") builds on the diagnostic and family ascertainment expertise of the Duke Center for Human Genetics. While the main goal of the core is to provide diagnostic expertise and facilitate the genetic family studies and other multidisciplinary efforts of Duke Udall PDRCE projects, the clinical data, DNA samples and tissue bank resources developed by the core will benefit other independently funded investigations of PD as well. There are three specific aims of the Ascertainment and Clinical Core: 1. Enroll 200 families in genetic studies of PD. 2. Maintain an active autopsy and tissue donation program. 3. Collect and database detailed clinical, family history, and environmental risk factor data on all participants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
7P50NS039764-09
Application #
7480982
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2007-06-01
Budget End
2008-05-31
Support Year
9
Fiscal Year
2007
Total Cost
$522,187
Indirect Cost
Name
University of Miami School of Medicine
Department
Type
DUNS #
052780918
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Nuytemans, Karen; Maldonado, Lizmarie; Ali, Aleena et al. (2016) Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants. Neurol Genet 2:e44
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129

Showing the most recent 10 out of 114 publications